Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$59.03T
24h Vol:
$10.08B
Dominance:
MSFT:5.13%
Stocklytics Platform
BETA
Instrument logo  ABBV

AbbVie Inc

ABBV
58 / 100
S&P500
$178.99arrow_drop_up0.10%$0.18
Key Stats
Open$178.77
Prev. Close$178.81
EPS2.72
Dividend$5.99
Next Earnings DateAug 13, 2024
Dividend Yield %3.47%
Market Cap$316.18B
PE Ratio65.81
LOWHIGH
Day Range176.98
179.53
52 Week Range130.96
179.78
Ratios
P/B Ratio30.49
Revenue$54.31B
Operating M. %31.81%
Earnings$4.88B
Earnings Growth %-58.78%
EBITDA Margin %48.53%
ROE %35.20%
EPS2.72
Fundamentals
RPS$30.72
Gross Profit$45.53B
EBITDA$18.09B
Total Debt$60.57B
P/S Ratio5.7x
Enterprise to EBITDA21.11
Profit Margin8.95%
ROA8.07%
Debt/Equity Ratio5.83%
Payout Ratio53.92%
Industry average yield3.02%
Last Dividend pay dateMay 15, 2024
Dividend per share$5.99
Dividend yield forecast0.03%

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

ABBVarrow_drop_up0.10%
US Healthcare Sectorarrow_drop_up1.17%
US Marketarrow_drop_up0.46%
ABBV / Market
ABBV lose to the US Market which returned 0.46% over the last twenty four hours.
ABBV / Healthcare Sector
ABBV lose to the US Healthcare sector which returned 1.17% over the last twenty four hours.

AbbVie Inc (ABBV) Statistics

AbbVie Inc, ABBV is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative therapies. The company's stock statistics show a positive trend, with consistent growth in the stock price over the years. With a market capitalization of over $100 billion, AbbVie Inc is one of the largest players in the pharmaceutical industry. Its valuation metrics indicate a healthy financial position and market value. The stock fundamentals reflect strong revenue and earnings growth, making AbbVie Inc an attractive investment option.

When comparing AbbVie Inc's stock performance to the sector, it is evident that the company has outperformed its peers. The stock has consistently generated higher returns for investors, showcasing the company's ability to thrive in a competitive market. The revenue per share for AbbVie Inc is impressive, indicating a strong sales performance and efficient operation. Additionally, the Enterprise to EBITDA ratio, which measures the company's ability to generate earnings from its operations, is favorable for AbbVie Inc.

add AbbVie Inc to watchlist

Keep an eye on AbbVie Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
How has AbbVie Inc (ABBV) stock's performance compared to its sector and the market over the past year?

Over the past year, AbbVie Inc (ABBV) has experienced a price change of 16.01%. Compared to the Healthcare sector, which saw a change of 33.58%, AbbVie Inc has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 40.25%, it has fallen short of the market average. This comparison highlights AbbVie Inc's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of AbbVie Inc (ABBV) stock?

The PE (Price to Earnings) ratio of AbbVie Inc (ABBV) is currently 65.81. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of AbbVie Inc (ABBV) stock?

The Earnings Per Share (EPS) for AbbVie Inc (ABBV), calculated on a diluted basis, is $2.72. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of AbbVie Inc (ABBV) stock?

The operating margin for AbbVie Inc (ABBV) is 31.81%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

question_mark
What is the EBITDA of AbbVie Inc (ABBV) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of AbbVie Inc (ABBV) is $18.1B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does AbbVie Inc (ABBV) have?

AbbVie Inc (ABBV) has a total debt of $60.58B. The net debt, which accounts for cash and cash equivalents against the total debt, is $46.57B.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.